Handling uncertainty in economic evaluations of patient level data: A review of the use of Bayesian methods to inform health technology assessments

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 4, 2009, Pages 546-554

  McCarron, C Elizabeth ^a   Pullenayegum, Eleanor M ^b   Marshall, Deborah A ^c   Goeree, Ron ^a,d   Tarride, Jean Eric ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Bayes theorem; Cost benefit analysis; Uncertainty

Indexed keywords

BAYESIAN NETWORKS; COST EFFECTIVENESS; COSTS; DECISION MAKING; ECONOMIC ANALYSIS; FUNCTION EVALUATION; UNCERTAINTY ANALYSIS;

BAYES THEOREM; ECONOMIC EVALUATIONS; HEALTH TECHNOLOGY ASSESSMENTS; HEALTH-CARE DECISIONS; LIKELIHOOD FUNCTIONS; POTENTIAL DEPENDENCE; SAMPLING UNCERTAINTIES; UNCERTAINTY;

COST BENEFIT ANALYSIS;

BAYES THEOREM; COST EFFECTIVENESS ANALYSIS; DATA BASE; ECONOMIC ASPECT; ECONOMIC EVALUATION; EMBASE; HEALTH CARE; HEALTH CARE POLICY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDLINE; PEDAGOGICS; REVIEW; SYSTEMATIC REVIEW; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST; DECISION MAKING; ECONOMICS; HUMAN; METHODOLOGY; UNCERTAINTY;

BAYES THEOREM; COSTS AND COST ANALYSIS; DECISION MAKING; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNCERTAINTY;

EID: 74049131261     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309990316     Document Type: Review

References (28)

1. Al MJ, Van Hout BA. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. Health Econ. 2000;9:599-609.
2. Ashby D. Bayesian statistics in medicine: A 25 year review. Stat Med. 2006;25:3589-3631.
3. Bachmann MO, Fairall L, Clark A, Mugford M. Methods for analyzing cost effectiveness data from cluster randomized trials. Cost Eff Resour Alloc. 2007;5:12.
4. Briggs AH. A Bayesian approach to stochastic costeffectiveness analysis: An illustration and application to blood pressure control in type 2 diabetes. Int J Technol Assess Health Care. 2001;17:69-82.
5. Briggs AH. handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479-500.
6. Drummond MF, SculpherMJ, TorranceGW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
7. Fenwick E, Wilson J, Sculpher M, Claxton K. Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis. Intensive Care Med. 2002;28:599-608.
8. Fryback DG, Chinnis JO, Ulvila JW. Bayesian costeffectiveness analysis: An example using the GUSTO trial. Int J Technol Assess Health Care. 2001;17:83-97.
9. Hahn S, Whitehead A. An illustration of the modelling of cost and efficacy data from a clinical trial. Stat Med. 2003;22:1009-1024.
10. Heitjan DF, Kim CY, Li H. Bayesian estimation of costeffectiveness from censored data. Stat Med. 2004;23:1297-1309.
11. Heitjan DF, Li H. Bayesian estimation of cost-effectiveness: An importance-sampling approach. Health Econ. 2004;13:191-198. (Pubitemid 38208180)
12. Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Econ. 1999;8:191-201.
13. Johnson-Masotti AP, Laud PW, Hoffmann RG, Hayat MJ, Pinkerton SD. Probabilistic cost-effectiveness analysis of HIV prevention comparing a Bayesian approach with traditional deterministic sensitivity analysis. Eval Rev. 2001;25:474-502.
14. Negrin MA, Vazquez-Polo FJ. Bayesian cost-effectiveness analysis with two measures of effectiveness: The costeffectiveness acceptability plane. Health Econ. 2006;15:363-372.
15. O'Hagan A, Luce BR. A primer on Bayesian statistics in health economics and outcomes research.Bayesian Initiative in Health Economics & Outcomes Research Centre for Bayesian Statistics in Health Economics; 2003.
16. O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis from clinical trial data. Health Econ. 2001;10:303-315. (Pubitemid 32605733)
17. O'Hagan A, Stevens JW. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res. 2002;11:469-490.
18. O'Hagan A, Stevens JW, Montmartin J. Bayesian costeffectiveness analysis from clinical trial data. Stat Med. 2001;20:733-753. (Pubitemid 32177846)
19. Ramsey S,WillkeR,Briggs A, et al.Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force Report. Value Health. 2005;8:521-533.
20. Shih YC, Bekele NB, Xu Y. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients. Pharmacoeconomics. 2007;25:843-862.
21. Skrepnek GH. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis. Pharmacoeconomics. 2007;25:649-664.
22. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. Chichester, West Sussex: John Wiley & Sons Ltd; 2004.
23. Stevens JW, O'Hagan A. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data. Int J Technol Assess Health Care. 2002;18:782-790.
24. Sung L, Hayden J, Greenberg ML, et al. Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol. 2005;58:261-268.
25. The BaSiS Group. Bayesian standards in science (BaSiS). http://lib.stat.cmu.edu/bayesworkshop/2001/BaSis.html. 2001.
26. UKBEAMTrial Team.UnitedKingdom back pain exercise and manipulation (UKBEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care. BMJ. 2004;329:1381-1385.
27. Vazquez-Polo FJ, Hernandez MAN, Lopez-Valcarcel BG. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data. Health Econ. 2005;14:545-557.
28. Vazquez-Polo FJ, Negrin M, Badia X, Roset M. Bayesian regression models for cost-effectiveness analysis. Eur J Health Econ. 2005;6:45-52.